JPRN-jRCTs061220039招募中未知
Efficucy and safty of transcatheter arterial micro-embolization for chronic post surgical pain after total knee arthroplasty
Sugimura Natsuki0 个研究点目标入组 20 人开始时间: 2022年7月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 50age old 至 < 90age old（—）
- 性别
- All
入选标准
- •Patients who meet all of the following criteria will be eligible.
- •(1) Patients who have undergone total knee arthroplasty (TKA) for osteoarthritis (OA) for at least one year at the time of consent.
- •(2) Patients with a pain VAS of 30 or higher at the time of consent.
- •(3) Patients whose age at the time of consent acquisition is between 50 and 90 years old.
- •(4) Patients with poor improvement after conservative therapy (NSAID patch, education, exercise therapy) for at least 3 months prior to obtaining consent (pain VAS 30 or higher).
排除标准
- •Patients who meet at least one of the following criteria will be excluded from the study. Patients who meet any one of the following criteria will not be allowed to participate in this study.
- •(1) Patients with active indications for surgical treatment (e.g. aseptic loosening)
- •(2) Patients with any of the following conditions: infection, rheumatoid arthritis, or mental illness.
- •(3) Patients with poor alignment
- •(4) Patients with actively suspected pain due to spinal lesions
- •(5) Patients with a high psychogenic predisposition to pain
- •(6) Patients with poorly controlled diabetesmellitus
- •(7) Patients taking antithrombotic medication which can not be suspended
- •(8) Patients with severely impaired renal function
- •(9) Patients with bronchial asthma
- •(10) Patients taking biguanide hypoglycemic agents which can not be suspended
- •(11) Patients taking valproic acid
- •(12) Patients with allergy to IPM/CS or contrast media
- •(13) Patients who are difficult to follow up in the hospital for one year.
- •(14) Patients deemed ineligible by the physician.
研究者
相似试验
未知
不适用
Safety and efficacy of transcatheter arterial micro-embolization for postherpetic neuralgia resistant to conservative treatmentJPRN-UMIN000025018Edogawa Hospital33
已完成
不适用
Safety and efficacy of transcatheter arterial micro embolization (TAME) using Imipenem / Cilastatin (IPM/CS) for chronic musculoskeletal pain refractory to non-surgical management.Musculoskeletal chronic pain refractory to non-surgical management(Glenohumeral joint, elbow joint, hip joint and knee joint)JPRN-UMIN000026094Tottori university, Faculty of medicine20
招募中
1 期
Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder painighttime shoulder pain refractory to traditional managementsJPRN-UMIN000017524Edogawa musculoskeletal intervention study group50
已完成
2 期
Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder pain : Multicenter Studynighttime shoulder pain refractory to non-surgical managementJPRN-UMIN000021238Edogawa Hospital100
招募中
1 期
Safety and Effectiveness of transcatheter arterial micro-embolization as a treatment for ulnar collateral ligament injuries in baseball players refractory to conservative treatmentJPRN-UMIN000025017Edogawa Hospital33